Trials / Completed
CompletedNCT03033264
Labor Induction With Dinoprostone in Oppose to Cervical Ripening Balloon as a Factor of BMI.
A Comparison Between Labor Induction With Dinoprostone and a Cervical Ripening Balloon in Women With a BMI>30 as Oppose With a BMI<30.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 164 (actual)
- Sponsor
- Rambam Health Care Campus · Academic / Other
- Sex
- Female
- Age
- 18 Years – 44 Years
- Healthy volunteers
- Accepted
Summary
Women with a BMI\>30 and women with a BMI\<30 will be divided in a randomized controlled manor to 4 groups depending on the mode of labor induction and BMI value: 1. Dinoprostone in women with a BMI\>30. 2. Dinoprostone in women with a BMI\<30. 3. Cervical ripening balloon in women with a BMI\>30. 4. Cervical ripening balloon in women with a BMI\<30. The subjects will be followed until labor, and information regarding the success of induction, mode of delivery and time of delivery will be collected from patients' electronic files.
Detailed description
The study is a randomized controlled test in which women with a BMI\>30 and women with a BMI\<30 will sign an informed consent and then divided to 4 groups depending on the mode of labor induction and BMI value: 1. Dinoprostone in women with a BMI\>30. 2. Dinoprostone in women with a BMI\<30. 3. Cervical ripening balloon in women with a BMI\>30. 4. Cervical ripening balloon in women with a BMI\<30. All subjects participating in the study will be induced for obstetrical indications alone. The subjects will be followed until labor, and information regarding the success of induction, mode of delivery and time of delivery will be collected from patients' electronic files. The participants will finish participation in the study after delivery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dinoprostone | 10 mg of a Dinoprostone vaginal insert. |
| DEVICE | Double lumen cervical ripening balloon. | Double lumen cervical ripening balloon. |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2020-07-31
- Completion
- 2020-10-01
- First posted
- 2017-01-26
- Last updated
- 2020-10-19
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT03033264. Inclusion in this directory is not an endorsement.